AttributesValues
rdf:type
Description
  • Sterile immunity against malaria can be achieved by the induction of IFNγ-producing CD8+ T cells that target infected hepatocytes presenting epitopes of the circumsporozoite protein (CSP). In the present study we evaluate the protective efficacy of a heterologous prime/boost immunization protocol based on the delivery of the CD8+ epitope of Plasmodium berghei CSP into the MHC class I presentation pathway, by either a type III secretion system of live recombinant Salmonella and/or by direct translocation of a recombinant Bordetella adenylate cyclase toxoid fusion (ACT-CSP) into the cytosol of professional antigen presenting cells (APCs). A single intraperitoneal application of the recombinant ACT-CSP toxoid, as well as a single oral immunization with the Salmonella vaccine, induced a specific CD8+ T cell response, which however conferred only a partial protection on mice against a subsequent sporozoite challenge
  • Sterile immunity against malaria can be achieved by the induction of IFNγ-producing CD8+ T cells that target infected hepatocytes presenting epitopes of the circumsporozoite protein (CSP). In the present study we evaluate the protective efficacy of a heterologous prime/boost immunization protocol based on the delivery of the CD8+ epitope of Plasmodium berghei CSP into the MHC class I presentation pathway, by either a type III secretion system of live recombinant Salmonella and/or by direct translocation of a recombinant Bordetella adenylate cyclase toxoid fusion (ACT-CSP) into the cytosol of professional antigen presenting cells (APCs). A single intraperitoneal application of the recombinant ACT-CSP toxoid, as well as a single oral immunization with the Salmonella vaccine, induced a specific CD8+ T cell response, which however conferred only a partial protection on mice against a subsequent sporozoite challenge (en)
  • Indukce specifické CTL buněčné odpovědi proti malarickému antigenu CSP zajišťuje ochranou imunitu proti malárii. V této práci jsme analyzovali roli prime/boost imunizačního protokolu v indukci CSP-zprostředkované ochranné imunity. Doprava CD8+ epitopu CSP do MHC-I dráhy antigenní prezentace pomocí rekombinantního ACT (ACT-CSP) anebo pomocí sekrečního systému typu III živé rekombinantní Salmonelly indukovala pouze částečnou ochranou imunitu. Avšak, použití prime/boost imunizačního protokolu vedlo k výraznému zvýšení CSP-specifických T buněk a kompletní protekci ve všech imunizovaných myších (cs)
Title
  • Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid
  • Prime/boost imunizační protokol antigenu CSP využívající sekreční systém typu III živé rekombinantní Salmonelly a rekombinantního ACT zajišťuje ochranou imunitu proti malarické infekci (cs)
  • Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid (en)
skos:prefLabel
  • Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid
  • Prime/boost imunizační protokol antigenu CSP využívající sekreční systém typu III živé rekombinantní Salmonelly a rekombinantního ACT zajišťuje ochranou imunitu proti malarické infekci (cs)
  • Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid (en)
skos:notation
  • RIV/61388971:_____/08:00315788!RIV09-AV0-61388971
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(2B06161), Z(AV0Z50200510)
http://linked.open...iv/cisloPeriodika
  • 47
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 360762
http://linked.open...ai/riv/idVysledku
  • RIV/61388971:_____/08:00315788
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • circumsporozoite protein; vaccine; salmonella (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [B34CC528B13C]
http://linked.open...i/riv/nazevZdroje
  • Vaccine
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 26
http://linked.open...iv/tvurceVysledku
  • Kamanová, Jana
  • Šebo, Peter
  • Fleischer, B.
  • Heussler, V.
  • Jacobs, T.
  • Tartz, S.
  • Sturm, A.
  • Rüssmann, H.
http://linked.open...ain/vavai/riv/wos
  • 000261750200008
http://linked.open...n/vavai/riv/zamer
issn
  • 0264-410X
number of pages
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software